Meeting
2020 ASCO Virtual Scientific Program
Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
Authors
Shijia Zhang
Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
Shijia Zhang , Ryan Shanley , Armin Rashidi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Allogenic Stem Cell Transplantation
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7541)
DOI
10.1200/JCO.2020.38.15_suppl.7541
Abstract #
7541
Poster Bd #
314
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Characterization of the microbial resistome in a prospective trial of CBM588 in metastatic renal cell carcinoma (mRCC) offers mechanism for interplay between antibiotic (abx) use and immune checkpoint inhibitor (ICI) activity.
First Author: Nazli Dizman
Poster
2024 ASCO Annual Meeting
Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT).
First Author: Doris M. Ponce
Poster
2023 ASCO Annual Meeting
A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation.
First Author: Doris M. Ponce
Poster
2022 ASCO Quality Care Symposium
Reducing time to antibiotics in patients with neutropenic fever on a bone marrow transplant unit.
First Author: Regina McGuire